MyDosageBeta
Canonical · evidence-anchored

GLP-1 starter (semaglutide titration)

Observed protocol pattern: 16-week semaglutide titration aligned with the Wegovy label.

16 weeks3 variantsrct3 evidence nodes
Outcomes this template targets
  • Weight / fat reduction
    Weight 100%
  • Appetite & food-noise suppression
    Weight 95%
  • Glycemic control
    Weight 75%
  • Caloric adherence
    Weight 60%
  • Cardiometabolic health
    Weight 55%
Pick a variant

Same template. Three intensities.

Gentle, Balanced, Advanced. We adjust dose curve, ramp, monitoring and check-in cadence — the science pattern stays identical.

Stack at balanced

Doses adjust with the variant.

  1. 01
    semaglutide
    Titrate per Wegovy USPI; never compress titration to manage tolerability.
    see variant
    weekly
Monitor
  • — weight
  • — waist
  • — nausea
  • — HbA1c at 12 weeks
  • — resistance-training adherence
Stop rules
  • — persistent intolerable GI
  • — pancreatitis signs
  • — no ≥5% weight loss by week 20 at target dose
Ready to run this?

Start a journey at the Balanced variant.

Begin onboarding